Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines

Many cancers have the tumor suppressor p53 inactivated by mutation, making reactivation of mutant p53 with small molecules a promising strategy for the development of novel anticancer therapeutics. The oncogenic p53 mutation Y220C, which accounts for approximately 100,000 cancer cases per year, crea...

Descripción completa

Detalles Bibliográficos
Autores principales: Baud, Matthias G.J., Bauer, Matthias R., Verduci, Lorena, Dingler, Felix A., Patel, Ketan J., Horil Roy, Deeptee, Joerger, Andreas C., Fersht, Alan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editions Scientifiques Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986712/
https://www.ncbi.nlm.nih.gov/pubmed/29702446
http://dx.doi.org/10.1016/j.ejmech.2018.04.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986712/
https://www.ncbi.nlm.nih.gov/pubmed/29702446
http://dx.doi.org/10.1016/j.ejmech.2018.04.035

Ejemplares similares